AlphaMaven AlphaMaven

Blue Sea Rides a Healthcare Wave to $800 Million

Reported by PE Professional
Nov 19, 2026· 3 min read
Save Post LinkedIn Email
Key Takeaways
  • • Blue Sea Capital closed its fourth fund, Fund IV, with $800 million in capital commitments, well above its $550 million target and its original $700 million hard cap, which was later raised.
  • • Fund IV is about 29% larger than Fund III, which closed in September 2023 with $618 million, and gathered commitments above the revised hard cap within four months of its May 2026 launch.
  • • Fund IV is Blue Sea's first fund dedicated solely to healthcare, targeting $40 million to $300 million of equity in companies with $5 million to $30 million EBITDA and $40 million to $500 million enterprise values.
  • • Blue Sea completed four exits in 2026 with a combined enterprise value of roughly $1.5 billion, including the WillowWood sale to CVC Catalyst.
  • • The raise comes as global healthcare buyout value reached an estimated $191 billion in 2025 per Bain & Company, while LP distributions have stayed below 15% of NAV for four straight years.
Summary
Blue Sea Capital has closed its fourth fund with $800 million of capital commitments, well above its $550 million target and its original $700 million hard cap, which was later raised. Fund IV, comprising Blue Sea Capital Fund IV LP and Blue Sea Capital Executive Fund IV LP, is about 29% larger than Fund III, which closed above target in September 2023 with $618 million. The firm launched the fund in May 2026 and gathered commitments above the revised hard cap in four months. Lazard was the global placement agent and Kirkland & Ellis provided legal services.

Fund IV is the first Blue Sea fund dedicated solely to healthcare, a sector the firm has invested in since its inception. The fund will focus on healthcare products and technology-enabled services, outsourced products and services, and multi-site services. Blue Sea invests $40 million to $300 million of equity in companies with EBITDA of $5 million to $30 million and enterprise values of $40 million to $500 million. It targets North American companies, typically through majority investments, and considers turnarounds only as add-ons. Its sector interests include healthcare technology, outsourced services, payor and employer services, pharma services and distribution, and medical, hospital and dental products and devices, among others. Managing partner J.R. Davis said the raise reflects investor conviction in dedicating the fund exclusively to healthcare, a vertical where the team has produced over 80% of equity value through growth.

Blue Sea completed four exits in 2026 with a combined enterprise value of approximately $1.5 billion. These included SignatureMD, a Florida concierge medicine provider; WillowWood, an Ohio prosthetics manufacturer sold to CVC Catalyst in June alongside reinvestment by Blue Sea, the Arbogast family and management; and One Physics, a Maryland outsourced medical physics provider retained through the firm's first continuation vehicle in July. The firm also added three platforms in 2026: Scout, a Texas clinical trial site support provider; CompletePet, a Florida pet wellness products company acquired from Align Capital Partners in September; and Dynamic Access, a Texas outsourced vascular access provider acquired in October.

The fundraise coincides with a strong period for healthcare private equity. According to Bain & Company's Global Healthcare Private Equity Report 2026, healthcare buyout transaction value reached an estimated $191 billion in 2025, a record that surpassed the 2021 peak, with 445 buyouts, the second-highest count on record. Healthcare exit values totaled an estimated $156 billion, up from $54 billion in 2024. Bain's Global Private Equity Report 2026 found that the broader fundraising environment is harder, with distributions to limited partners below 15% of net asset value for four consecutive years, leaving LPs focused on the largest platforms and top-tier performers. Blue Sea was founded in 2013 by J.R. Davis and Rick Wandoff, is headquartered in West Palm Beach, Florida, and manages more than $2.5 billion.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

PE Professional Blue Sea Rides a Healthcare Wave to $800 Million